The Department of Dermatology, one of the oldest in the country, is deeply rooted in research. Our clinical research efforts contributed significantly to the treatment of advanced skin tumors such as melanoma. At present, we are actively exploring new uses of photopheresis, a technology first created at Yale Medicine to treat such life-threatening and debilitating diseases as cutaneous T-cell lymphoma and graft versus host disease.
A large portion of our research is performed through two separate research entities: the Yale SPORE in Skin Cancer Center, focused on improving the prevention, diagnosis, and treatment of melanomas, and the Spitzoid Neoplasm Repository, dedicated to finding the genetic causes of skin abnormalities.
Clinical trials at Yale are vital to advancing research and bringing the newest treatments and technologies to patients as quickly and safely as possible.
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.